| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | Director | Common Stock | 69.5K | $1.29M | $18.55 | Jun 10, 2025 | Direct |
| Acutus Medical, Inc. | Director | Common Stock | 508K | $792K | $1.56 | Oct 1, 2022 | By Front Foot Trust |
| Acutus Medical, Inc. | Director | FORM 4 | 508K | $95.9K | $0.19 | Jun 15, 2023 | By Front Foot Trust |
| QuidelOrtho Corp | Director | Common Stock | 2.52K | $70.1K | $27.78 | May 22, 2025 | Direct |
| Acutus Medical, Inc. | Director | Common Stock | 10.9K | $17K | $1.56 | Oct 1, 2022 | Direct |
| Acutus Medical, Inc. | Director | FORM 4 | 21.8K | $4.13K | $0.19 | Jun 15, 2023 | Direct |
| Hyperfine, Inc. | Director | Stock Options (right to buy) | 79.2K | Jun 12, 2024 | Direct | ||
| NeuroPace Inc | Director | Stock Option (right to buy) | 8.75K | Jun 6, 2025 | Direct | ||
| QuidelOrtho Corp | Director | Restricted Stock Units (Equity Grant) | 6.83K | May 29, 2025 | Direct | ||
| Acutus Medical, Inc. | Director | Stock Options (Right to Buy) | 5.88K | Oct 1, 2022 | Direct | ||
| NUVASIVE INC | Director | RSUs | 4.82K | Jun 9, 2023 | Direct | ||
| NUVASIVE INC | Director | Common Stock, par value $0.001 per share | 0 | $42.67 | Sep 1, 2023 | Direct | |
| NUVASIVE INC | Director | Restricted Stock Unit | 0 | Sep 1, 2023 | Direct | ||
| QuidelOrtho Corp | Director | No securities beneficially owned. | 0 | Dec 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVST | Envista Holdings Corp | Jun 10, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
| NPCE | NeuroPace Inc | Jun 6, 2025 | 1 | $0 | 4 | Jun 9, 2025 | Director |
| QDEL | QuidelOrtho Corp | May 29, 2025 | 1 | $0 | 4 | Jun 2, 2025 | Director |
| QDEL | QuidelOrtho Corp | May 22, 2025 | 2 | $0 | 4 | May 27, 2025 | Director |
| NPCE | NeuroPace Inc | Jan 6, 2025 | 1 | $0 | 4 | Jan 8, 2025 | Director |
| NPCE | NeuroPace Inc | Jan 6, 2025 | 0 | $0 | 3 | Jan 8, 2025 | Director |
| QDEL | QuidelOrtho Corp | Dec 6, 2024 | 0 | $0 | 3 | Dec 10, 2024 | Director |
| HYPR | Hyperfine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
| NVST | Envista Holdings Corp | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| NUVA | NUVASIVE INC | Sep 1, 2023 | 6 | $0 | 4 | Sep 5, 2023 | Director |
| AFIB | Acutus Medical, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
| NUVA | NUVASIVE INC | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| HYPR | Hyperfine, Inc. | Jun 9, 2023 | 3 | $0 | 4 | Jun 12, 2023 | Director |
| NVST | Envista Holdings Corp | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| HYPR | Hyperfine, Inc. | Oct 31, 2022 | 8 | $0 | 4 | Nov 1, 2022 | Director |
| AFIB | Acutus Medical, Inc. | Oct 1, 2022 | 2 | $0 | 4 | Oct 11, 2022 | Director |
| AFIB | Acutus Medical, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
| HYPR | Hyperfine, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| AFIB | Acutus Medical, Inc. | Jun 3, 2022 | 1 | -$34.8K | 4 | Jun 3, 2022 | Director |
| NVST | Envista Holdings Corp | May 24, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| NUVA | NUVASIVE INC | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| HYPR | Hyperfine, Inc. | Mar 29, 2022 | 1 | $0 | 4 | Mar 31, 2022 | Director |
| HYPR | Hyperfine, Inc. | Dec 22, 2021 | 4 | $0 | 4/A | Jan 10, 2022 | Director |
| HYPR | Hyperfine, Inc. | Dec 22, 2021 | 0 | $0 | 3 | Dec 23, 2021 | Director |
| NVST | Envista Holdings Corp | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
| NUVA | NUVASIVE INC | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |